The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Brzheskiĭ V.V.

GBOU VPO "Sankt-Peterburgskiĭ gosudarstvennyĭ pediatricheskiĭ meditsinskiĭ universitet" Minzdrava Rossii

Popov V.Yu.

Saint Petersburg State Pediatric Medical University, 2 Litovskaya St., Saint Petersburg, Russian Federation, 194100;
Mariinsky City Hospital, 56 Liteinyi Prospect, Saint Petersburg, Russian Federation, 194104

Kalinina N.M.

Nikiforov All-Russian Center of Emergency and Radiation Medicine, the Emergencies Ministry of Russia, 4/2 Akademika Lebedeva St., Saint Petersburg, Russian Federation, 194044

Brzheskaya I.V.

Saint Petersburg State Pediatric Medical University, 2 Litovskaya St., Saint Petersburg, Russian Federation, 194100;
Mariinsky City Hospital, 56 Liteinyi Prospect, Saint Petersburg, Russian Federation, 194104

Prevention and treatment of degenerative changes in ocular surface epithelium in patients with dry eye syndrome

Authors:

Brzheskiĭ V.V., Popov V.Yu., Kalinina N.M., Brzheskaya I.V.

More about the authors

Journal: Russian Annals of Ophthalmology. 2018;134(5): 126‑134

DOI: 10.17116/oftalma2018134051126

Read: 1776 times

Download PDF (RU)
Contact the author
Table of contents

PREVENTION AND TREATMENT OF DEGENERATIVE CHANGES IN OCULAR SURFACE EPITHELIUM IN PATIENTS WITH DRY EYE SYNDROME
PREVENTION AND TREATMENT OF DEGENERATIVE CHANGES IN OCULAR SURFACE EPITHELIUM IN PATIENTS WITH DRY EYE SYNDROME

To cite this article:

Brzheskiĭ VV, Popov VYu, Kalinina NM, Brzheskaya IV. Prevention and treatment of degenerative changes in ocular surface epithelium in patients with dry eye syndrome. Russian Annals of Ophthalmology. 2018;134(5):126‑134. (In Russ.)
https://doi.org/10.17116/oftalma2018134051126

Подписка 2026 Вестник офтальмологии (Russian Annals of Ophthalmology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Approaches for improvement of ocular surface condition in primary open-angle glaucoma. Russian Annals of Ophthalmology. 2024;(5):7-16
Oxidative stress in the pathogenesis of chro­nic headache. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):35-40
Alte­rations in the acti­vity of glutathione-dependent enzy­mes in erythrocytes of patients with acute pancreatitis of varying seve­rity. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):10-15
Oxidative stress and antioxidant protection in diso­rders of cere­bral circulation. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):114-119
Evaluation of the effi­ciency of combined pharmaco-physiotherapy in patients with dry eye syndrome. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):91-95
Arte­rial hype­rtension is an oxidative stress, as a pathogenetic target for the treatment of chro­nic cere­brovascular insu­fficiency. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):84-90
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21
Sleep deprivation and the deve­lopment of oxidative stress in animal models. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):124-129
The main mechanisms of deve­lopment of cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):13-18
The known and new ideas about the mechanism of action and the spectrum of effe­cts of Mexi­dol. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):22-33
Abstract:

In current understanding of the pathogenesis of xerotic changes of the ocular surface in patients with dry eye syndrome (DES), great importance is given to hyperosmolarity of the tear film, inflammatory process and oxidative stress. By now, no convincing data has been obtained on whether the oxidative stress is primary in relation to the inflammatory process in the ocular surface tissues, or if it is a complication. Furthermore, in the complex treatment of patients with DES, antioxidant therapy has so far received little attention. This problem can be solved with the «artificial tears» preparation containing cyanocobalamin (vitamin B12), which antioxidant, anti-inflammatory and clinical effectiveness has been convincingly proved in a number of experimental and clinical studies of recent years. Improving the methods of vital diagnostics of xerosis of the ocular surface also enables detection of subclinical changes in epithelium of the cornea and conjunctiva, thus allowing timely prescription of metabolic therapy. One of the promising directions of such treatment is the use of 5% dexpanthenol, which stimulates the processes of reparative regeneration and possesses an anti-inflammatory effect.

Keywords:

dry eye syndrome
xerosis of the ocular surface
oxidative stress
antioxidant
metabolic therapy

Authors:

Brzheskiĭ V.V.

GBOU VPO "Sankt-Peterburgskiĭ gosudarstvennyĭ pediatricheskiĭ meditsinskiĭ universitet" Minzdrava Rossii

Popov V.Yu.

Saint Petersburg State Pediatric Medical University, 2 Litovskaya St., Saint Petersburg, Russian Federation, 194100;
Mariinsky City Hospital, 56 Liteinyi Prospect, Saint Petersburg, Russian Federation, 194104

Kalinina N.M.

Nikiforov All-Russian Center of Emergency and Radiation Medicine, the Emergencies Ministry of Russia, 4/2 Akademika Lebedeva St., Saint Petersburg, Russian Federation, 194044

Brzheskaya I.V.

Saint Petersburg State Pediatric Medical University, 2 Litovskaya St., Saint Petersburg, Russian Federation, 194100;
Mariinsky City Hospital, 56 Liteinyi Prospect, Saint Petersburg, Russian Federation, 194104

Close metadata

References:

  1. Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15(3):438-510.
  2. https://doi.org/10.1016/j.jtos.2017.05.011
  3. Brzheskiy VV. «Ocular surface» and other terms. Vestnik oftal’mologii. 2014;130(6):108-109. (In Russ.)
  4. Brzheskiy VV, Egorova GB, Egorov EA. Sindrom «sukhogo glaza» i zabolevaniya glaznoi poverkhnosti: klinika, diagnostika, lechenie. M.: GEOTAR-Media; 2016. (In Russ.)
  5. Li DQ, Chen Z, Song XJ, et al. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2004;45(12):4302-4311.
  6. https://doi.org/10.1167/iovs.04-0299
  7. Kalinina NM, Popov VYu, Brzheskiy VV. The role of lacrimal fluid cytokines in the development of dry eye disease (review). Tsitokiny i vospalenie. 2015;14(1):11-15 (In Russ.)
  8. De Paiva CS, Corrales RM, Villarreal AL, et al. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res. 2006;83(3):526-535. https://doi.org/10.1016/j.exer.2006.02.004
  9. Benitez-Del-Castillo JM, Acosta MC, Wassfi MA, et al. Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye. Invest Ophthalmol Vis Sci. 2007;48(1):173-181. https://doi.org/10.1167/iovs.06-0127
  10. Brzesky VV, Kalinina IV, Kalinina NM, Popov VYu. The role of oxidative stress in the pathogenesis of dry eye syndrome and the possibility of its correction. Glaz. 2016;6(106):9-15. (In Russ.)
  11. Behndig A, Karlsson K, Johansson BO, et al. Superoxide dismutase isoenzymes in the normal and diseased human cornea. Invest Ophthalmol Vis Sci. 2001;42(10):2293-2296.
  12. Wakamatsu TH. Evaluation of lipid oxidative stress status and inflammation in atopic ocular surface disease. Mol Vis. 2010;16:2465-2475.
  13. Ward SK, Wakamatsu TH, Dogru M, et al. The role of oxidative stress and inflammation in conjunctivochalasis. Invest Ophthalmol Vis Sci. 2010;51(4):1994-2002. https://doi.org/10.1167/iovs.09-4130
  14. Nakamura S, Shibuya M, Nakashima H et al. Involvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eye. Invest Ophthalmol Vis Sci. 2007;48(4):1552-1558. https://doi.org/10.1167/iovs.06-1027
  15. Deng R, Hua X, Li J, et al. Oxidative stress markers induced by hyperosmolarity in primary human corneal epithelial cells. PLoS One. 2015;10(5):1-16.
  16. https://doi.org/10.1371/journal.pone.0126561
  17. Norheim KB, Jonsson G, Harboe1 E et al. Oxidative stress, as measured by protein oxidation, is increased in primary Sjogren’s syndrome. Free Radic Res. 2012;46(2):141-146. https://doi.org/10.3109/10715762.2011.645206
  18. Macri A, Scanarotti Ch, Bassi AM, et al. Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15% and vitamin B12 eye drops. Graefes Arch Clin Exp Ophthalmol. 2015;253(3):425-430.
  19. https://doi.org/10.1007/s00417-014-2853-6
  20. Wakamatsu TH, Dogru M, Matsumoto Y, et al. Evaluation of lipid oxidative stress status in Sjogren syndrome patients. Invest Ophthalmol Vis Sci. 2013;54(1):201-210. https://doi.org/10.1167/iovs
  21. Pagano G, Castello G, Pallardo FV. Sjogren’s syndrome-associated oxidative stress and mitochondrial dysfunction: Prospects for chemoprevention trials. Free Radic Res. 2013;47(2):71-73.
  22. https://doi.org/10.3109/10715762.2012.748904
  23. Uchino Y, Kawakita T, Miyazawa M, et al. Oxidative stress induced inflammation initiates functional decline of tear production. PLoS One. 2012;7(10):1-8. https://doi.org/10.1371/journal.pone.0045805
  24. Baudouin C, Haouat N, Brignole F, et al. Immunopathological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens. Br J Ophthalmol. 1992;76(9):545-549.
  25. Dalle-Donne I, Rossi R, Colombo R, et al. Biomarkers of oxidative damage in human disease. Clin Chem. 2006;52(4):601-623.
  26. https://doi.org/10.1373/clinchem.2005.061408
  27. Cejková J, Ardan T, Simonová Z, et al. Decreased expression of antioxidant enzymes in the conjunctival epithelium of dry eye (Sjögren’s syndrome) and its possible contribution to the development of ocular surface oxidative injuries. Histol Histopathol. 2008;23(12):1477-1483.
  28. https://doi.org/10.14670/HH-23.1477
  29. Fujikura S, Davis PA, Prindiville T, et al. Sjögren’s syndrome and primary biliary cirrhosis: presence of autoantibodies to purified mitochondrial 2-OXO acid dehydrogenases. J Rheumatol. 1990;17(1):1453-1457.
  30. Skopouli FN, Barbatis C, Moutsopoulos HM. Liver involvement in primary Sjögren’s syndrome. Br J Rheumatol. 1994;33(8):745-748.
  31. Safonova TN, Gladkova OV, Boev VI. Significance of laser confocal tomography in diagnosis and monitoring of keratoconjunctivitis sicca. Vestnik oftal’mologii. 2016;132(2):47-54. (In Russ.)
  32. https://doi.org/10.17116/oftalma2016132247-54
  33. Echova EA, Fokin VP, Balalin SV, Melikhova IA. Influence of ortokeratological contact lenses on morphofunctional properties of the cornea in myopic children and adolescents on the basis of the findings of confocal microscopy. Vestnik VolgGMU. 2015;1(53):47-49. (In Russ.)
  34. Becker LC, Bergfeld WF, Belsito DV et al. Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate. Intern J Toxicol. 2009;28(4):5-67.
  35. https://doi.org/10.1177/1091581809337738
  36. Prosdocimi M, Bevilacqua C. Exogenous hyaluronic acid and wound healing: an updated vision. Panminerva Med. 2012;54(2):129-135.
  37. Brjesky VV, Maychuk YF, Petrayevsky AV, Nagorsky PG. Use of preservative-free hyaluronic acid (Hylabak) for a range of patients with dry eye syndrome: experience in Russia. Clin Ophthalmol. 2014;8:1169-1177.
  38. https://doi.org/10.2147/OPTH.S47713
  39. Brzheskiy VV, Golubev SYu. Potential for use of hydroxypropyl guar in tear substitute therapy. Vestnik oftal’mologii. 2017;133(1):88-96. (In Russ.) https://doi.org/10.17116/oftalma2017133188-96
  40. Jones L, Downie LE, Korb D et al. TFOS DEWS II Management and therapy report. Ocul Surf. 2017;15(3):575-628.
  41. https://doi.org/10.1016/j.jtos.2017.05.006
  42. Ma’ltsev DS, Kudryashova EV. Cyanocobalamin-containing lubricant for topical therapy of LASIK-associated dry eye. Vestnik ophthal’mologii. 2016;132(1):68-75. (In Russ.) https://doi.org/10.17116/oftalma2016132168-75
  43. Sheppard JD, Shah NS, DiSandro G, Anthony B. Anti-inflammatory therapy for dry eye disease: rationale and strategy. In: Benitez-del-Castillo JM, Lemp MA. Ocular surface disorders. London etc.: JP Medical Publishers; 2013.
  44. Versura P, Profazio V, Giuseppe Giannaccare G et al. Discomfort symptoms reduction and ocular surface parameters recovery with Artelac Rebalance treatment in mild—moderate dry eye. Europ J Ophthalmol. 2013;23(4):488-495. https://doi.org/10.5301/ejo.5000267
  45. Brzheskiy VV, Efimova EL, Vorontsova TN et al. Results of a multicenter, randomized, double-masked, placebo-controlled clinical study of the efficacy and safety of visomitin eye drops in patients with dry eye syndrome. Adv Ther. 2015;32(12):1263-1279. https://doi.org/10.1007/s12325-015-0273-6
  46. Egorova GB, Mitichkina TS, Shamsudinova AR. Corneal protection in contact lens users. Vestnik oftal’mologii. 2014;130(2):57-64. (In Russ.)
  47. Egorov EA, Kalinich NI, Kiyasov AP. New stimulators of reparative regeneration of the cornea. Vestnik ophthal’mologii. 1999;115(6):13-16. (In Russ.)
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.